CD133 silencing inhibits stemness properties and enhances chemoradiosensitivity in CD133-positive liver cancer stem cells

Author：                

Publisher： Spandidos Publications

ISSN： 1107-3756

Source： International Journal of Molecular Medicine, Vol.31, Iss.2, 2013-01, pp. : 315-324

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Coexpression of CD44‐positive/CD133‐positive cancer stem cells and CD204‐positive tumor‐associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma

By  

CANCER, Vol. 120, Iss. 17, 2014-09 ,pp. : 2766-2777

John Wiley & Sons Inc

Access to resources Recommend Favorite

The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells

By Bidlingmaier Scott  

Journal of Molecular Medicine, Vol. 86, Iss. 9, 2008-09 ,pp. : 1025-1032

Springer Publishing Company

Access to resources Recommend Favorite

Therapeutic angiogenesis by transplantation of human embryonic stem cell-derived CD133+ endothelial progenitor cells for cardiac repair

By Rufaihah Abdul Jalil   Haider Husnain Khawaja   Heng Boon Chin   Ye Lei   Tan Ru San   Toh Wei Seong   Tian Xian Feng   Sim Eugene Kwang-Wei   Cao Tong  

Regenerative Medicine, Vol. 5, Iss. 2, 2010-03 ,pp. : 231-244

Future Medicine

Access to resources Recommend Favorite

Prominin-1 (CD133): from progenitor cells to human diseases

By Fargeas Christine A   Fonseca Ana-Violeta   Huttner Wieland B   Corbeil Denis  

Future Lipidology, Vol. 1, Iss. 2, 2006-04 ,pp. : 213-225

Future Medicine

Access to resources Recommend Favorite